Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 6
1976 19
1977 16
1978 28
1979 16
1980 15
1981 27
1982 24
1983 32
1984 39
1985 67
1986 114
1987 125
1988 107
1989 55
1990 47
1991 46
1992 60
1993 104
1994 99
1995 96
1996 123
1997 120
1998 102
1999 150
2000 137
2001 136
2002 139
2003 180
2004 153
2005 171
2006 144
2007 154
2008 166
2009 141
2010 164
2011 147
2012 175
2013 168
2014 174
2015 157
2016 164
2017 138
2018 127
2019 96
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

4,407 results
Results by year
Filters applied: . Clear all
Page 1
Somatostatin and diabetic retinopathy: an evolving story.
Simó-Servat O, Hernández C, Simó R. Simó-Servat O, et al. Endocrine. 2018 Apr;60(1):1-3. doi: 10.1007/s12020-018-1561-0. Epub 2018 Feb 20. Endocrine. 2018. PMID: 29464407 No abstract available.
Somatostatin Analogues Compared With Placebo and Other Pharmacologic Agents in the Management of Symptoms of Inoperable Malignant Bowel Obstruction: A Systematic Review.
Obita GP, Boland EG, Currow DC, Johnson MJ, Boland JW. Obita GP, et al. J Pain Symptom Manage. 2016 Dec;52(6):901-919.e1. doi: 10.1016/j.jpainsymman.2016.05.032. Epub 2016 Sep 30. J Pain Symptom Manage. 2016. PMID: 27697568 Free article. Review.
The history of somatostatin analogs.
Pless J. Pless J. J Endocrinol Invest. 2005;28(11 Suppl International):1-4. J Endocrinol Invest. 2005. PMID: 16625837
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial.
Lacroix A, Gu F, Gallardo W, Pivonello R, Yu Y, Witek P, Boscaro M, Salvatori R, Yamada M, Tauchmanova L, Roughton M, Ravichandran S, Petersenn S, Biller BMK, Newell-Price J; Pasireotide G2304 Study Group. Lacroix A, et al. Lancet Diabetes Endocrinol. 2018 Jan;6(1):17-26. doi: 10.1016/S2213-8587(17)30326-1. Epub 2017 Oct 12. Lancet Diabetes Endocrinol. 2018. PMID: 29032078 Clinical Trial.
4,407 results
Jump to page
Feedback